FDA and Drug Litigation |
Article: FDA Accuses Bayer of Mislabeling and Misbranding AspirinsThe U.S. Food and Drug Administration (FDA) has sent a letter to German-based pharmaceutical giant Bayer, already under fire over the Trasylol scandal, and is accusing the drug maker of misbranding, mislabeling and confusing customers about two of its over the counter products - Bayer Women's Low Dose Aspirin & Calcium and Bayer Aspirin with Heart Advantage.
What Bayer is saying Here's how Bayer Health Care, a subsidiary of Bayer, is branding and labeling these products:
Why the FDA says it's not allowed… In a nutshell, the FDA is saying that because the drugs are "more than just aspirin," they fall under a different category of drugs and are therefore subject to greater scrutiny under the FDA's guidelines. The FDA has given Bayer 15 days to advise it of the steps it has taken to correct the violations and has threatened the drug maker with legal action without further notice, including, without limitation, seizure and injunction. If you've been injured due to a dangerous drug, contact an experienced attorney whose practice focuses in the areas of personal injury, products liability, medical malpractice or any other practice area to discuss your situation. Consultations are free, without obligation and are strictly confidential. Articles & Information:Proposed FDA Warning Requirements Not Consumer Friendly Study Finds Drug Makers Not Reporting All Trial Results Consumer Group Claims Botox Injections Linked To 16 Deaths FDA Gets More Money – But Will It Really Help Consumers? View all articles |